UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The cost of relapse and the predictors of relapse in the treatment of schizophrenia

BMC psychiatry, 2010-01, Vol.10 (1), p.2-2, Article 2

2010

Volltextzugriff (PDF)

Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia

BMC psychiatry, 2006-02, Vol.6 (1), p.8-8, Article 8

2006

Volltextzugriff (PDF)

Classifying Patients by Antipsychotic Adherence Patterns Using Latent Class Analysis: Characteristics of Nonadherent Groups in the California Medicaid (Medi-Cal) Program

Value in health, 2008, Vol.11 (1), p.48-56

2008

Volltextzugriff (PDF)

Item response analysis of the Positive and Negative Syndrome Scale

BMC psychiatry, 2007-11, Vol.7 (1), p.66-66, Article 66

2007

Volltextzugriff (PDF)

Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care

The journal of clinical psychiatry, 2006-03, Vol.67 (3), p.453-460

2006

Volltextzugriff (PDF)

Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia

Neuropsychopharmacology (New York, N.Y.), 2010-01, Vol.35 (2), p.581-590

2010

Volltextzugriff (PDF)

Improved outcomes following a switch to olanzapine treatment from risperidone treatment in a 1-year naturalistic study of schizophrenia patients in Japan

Psychiatry and clinical neurosciences, 2012-06, Vol.66 (4), p.313-321

2012

Volltextzugriff (PDF)

Cognitive and Functional Decline in Patients With Mild Alzheimer Dementia With or Without Comorbid Diabetes

Clinical therapeutics, 2015-06, Vol.37 (6), p.1195-1205

2015

Volltextzugriff (PDF)

The relationship, structure and profiles of schizophrenia measurements: a post-hoc analysis of the baseline measures from a randomized clinical trial

BMC psychiatry, 2011-12, Vol.11 (1), p.203-203, Article 203

2011

Volltextzugriff (PDF)

Characteristics and Use Patterns of Patients Taking First-Generation Depot Antipsychotics or Oral Antipsychotics for Schizophrenia

Psychiatric services (Washington, D.C.), 2007-04, Vol.58 (4), p.482-488

2007

Volltextzugriff (PDF)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

BMC psychiatry, 2005-05, Vol.5 (1), p.26-26, Article 26

2005

Volltextzugriff (PDF)

Long-term healthcare costs and functional outcomes associated with lack of remission in schizophrenia: a post-hoc analysis of a prospective observational study

BMC psychiatry, 2012-12, Vol.12 (1), p.222-222, Article 222

2012

Volltextzugriff (PDF)

Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis

Diabetes therapy, 2015-09, Vol.6 (3), p.303-316

2015

Volltextzugriff (PDF)

Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia

ClinicoEconomics and outcomes research, 2011-01, Vol.3 (default), p.9-14

2011

Volltextzugriff (PDF)

Predictors of switching antipsychotic medications in the treatment of schizophrenia

BMC psychiatry, 2010-09, Vol.10 (1), p.75-75, Article 75

2010

Volltextzugriff (PDF)

Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia

BMC psychiatry, 2009-09, Vol.9 (1), p.54-54, Article 54

2009

Volltextzugriff (PDF)

Medication adherence levels and differential use of mental-health services in the treatment of schizophrenia

BMC research notes, 2009-01, Vol.2 (1), p.6-6

2009

Volltextzugriff (PDF)

Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia

BMC psychiatry, 2010-01, Vol.10 (1), p.11-11, Article 11

2010

Volltextzugriff (PDF)

Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia

BMC psychiatry, 2005-01, Vol.5 (1), p.3-3, Article 3

2005

Volltextzugriff (PDF)

Cost of antipsychotic polypharmacy in the treatment of schizophrenia

BMC psychiatry, 2008-04, Vol.8 (1), p.19-19, Article 19

2008

Volltextzugriff (PDF)

Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients

BMC psychiatry, 2009-07, Vol.9 (1), p.46-46, Article 46

2009

Volltextzugriff (PDF)

Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients' and clinicians' perspectives in a clinical trial

BMC medical research methodology, 2012-09, Vol.12 (1), p.142-142, Article 142

2012

Volltextzugriff (PDF)

Predictors of metabolic monitoring among schizophrenia patients with a new episode of second-generation antipsychotic use in the Veterans Health Administration

BMC psychiatry, 2009-12, Vol.9 (1), p.80-80, Article 80

2009

Volltextzugriff (PDF)

Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis

Diabetes therapy, 2015-09, Vol.6 (3), p.317-328

2015

Volltextzugriff (PDF)

Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia

BMC psychiatry, 2011-02, Vol.11 (1), p.23-23, Article 23

2011

Volltextzugriff (PDF)

1 – 25 von 164

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(134)

Publikationsform

Sprache

Englisch
(164)
Türkisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(101)
Science & Technology
(101)
Schizophrenia
(87)
Humans
(86)
Psychiatry
(85)
Female
(71)
Male
(69)
Adult
(65)
Schizophrenia - Drug Therapy
(64)
Antipsychotic Agents - Therapeutic Use
(60)
Treatment Outcome
(43)
Middle Aged
(39)
Olanzapine
(35)
Biological And Medical Sciences
(33)
Medical Sciences
(33)
Schizophrenic Psychology
(33)
Psychology. Psychoanalysis. Psychiatry
(32)
Antipsychotics
(29)
Benzodiazepines - Therapeutic Use
(28)
Psychopathology. Psychiatry
(28)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The cost of relapse and the predictors of relapse in the treatment of schizophrenia

Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia

Classifying Patients by Antipsychotic Adherence Patterns Using Latent Class Analysis: Characteristics of Nonadherent Groups in the California Medicaid (Medi-Cal) Program

Item response analysis of the Positive and Negative Syndrome Scale

Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care

Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia

Improved outcomes following a switch to olanzapine treatment from risperidone treatment in a 1-year naturalistic study of schizophrenia patients in Japan

Cognitive and Functional Decline in Patients With Mild Alzheimer Dementia With or Without Comorbid Diabetes

The relationship, structure and profiles of schizophrenia measurements: a post-hoc analysis of the baseline measures from a randomized clinical trial

Characteristics and Use Patterns of Patients Taking First-Generation Depot Antipsychotics or Oral Antipsychotics for Schizophrenia

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

Long-term healthcare costs and functional outcomes associated with lack of remission in schizophrenia: a post-hoc analysis of a prospective observational study

Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis

Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia

Predictors of switching antipsychotic medications in the treatment of schizophrenia

Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia

Medication adherence levels and differential use of mental-health services in the treatment of schizophrenia

Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia

Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia

Cost of antipsychotic polypharmacy in the treatment of schizophrenia

Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients

Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients' and clinicians' perspectives in a clinical trial

Predictors of metabolic monitoring among schizophrenia patients with a new episode of second-generation antipsychotic use in the Veterans Health Administration

Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis

Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia

Suchergebnisse filtern